Why insider trading matters?
When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-06-21 | EHRLICH JASON | nan | Sell | 6,950 | $84.90 | $590,085 | No |
| 2021-06-15 | EHRLICH JASON | nan | Sell | 1,454 | $80.90 | $117,624 | Yes |
| 2021-06-15 | BORGESON JOHN A. | nan | Sell | 1,290 | $80.90 | $104,361 | Yes |
| 2021-06-15 | EHRLICH JASON | nan | Sell | 1,147 | $84.75 | $97,208 | Yes |
| 2021-06-15 | BORGESON JOHN A. | nan | Sell | 1,037 | $84.75 | $87,886 | Yes |
| 2021-05-20 | EHRLICH JASON | nan | Sell | 6,950 | $81.14 | $563,924 | No |
| 2021-04-20 | EHRLICH JASON | nan | Sell | 6,950 | $111.26 | $773,249 | Yes |
| 2021-03-22 | EHRLICH JASON | nan | Sell | 6,950 | $131.50 | $913,894 | Yes |
| 2021-03-10 | BORGESON JOHN A. | nan | Sell | 5,000 | $130.08 | $650,415 | No |
| 2021-02-22 | EHRLICH JASON | nan | Sell | 6,950 | $125.81 | $874,367 | Yes |
| 2021-01-20 | EHRLICH JASON | nan | Sell | 26,950 | $162.77 | $4,386,776 | Yes |
| 2020-12-23 | EHRLICH JASON | nan | Sell | 6,950 | $144.55 | $1,004,610 | Yes |
| 2020-11-20 | EHRLICH JASON | nan | Sell | 6,950 | $138.79 | $964,601 | Yes |
| 2020-11-20 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 1,527,777 | $108.00 | $164,999,916 | No |
| 2020-10-27 | EHRLICH JASON | nan | Sell | 7,500 | $100.00 | $750,000 | Yes |
| 2020-10-23 | EHRLICH JASON | nan | Sell | 7,500 | $86.25 | $646,875 | Yes |
| 2020-10-20 | EHRLICH JASON | nan | Sell | 6,950 | $78.39 | $544,817 | Yes |
| 2020-10-13 | EHRLICH JASON | nan | Sell | 5,000 | $75.00 | $375,000 | Yes |
| 2020-10-09 | EHRLICH JASON | nan | Sell | 2,200 | $71.28 | $156,819 | Yes |
| 2020-09-25 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 48,125 | $56.65 | $2,726,182 | No |
| 2020-09-24 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 203,047 | $51.71 | $10,498,591 | No |
| 2020-09-21 | EHRLICH JASON | nan | Sell | 6,950 | $52.40 | $364,182 | Yes |
| 2020-09-08 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 322,979 | $47.43 | $15,318,311 | No |
| 2020-08-20 | EHRLICH JASON | nan | Sell | 6,950 | $47.11 | $327,444 | Yes |
| 2020-08-21 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 203,486 | $48.23 | $9,815,002 | No |
| 2020-07-20 | EHRLICH JASON | nan | Sell | 6,950 | $50.44 | $350,526 | Yes |
| 2020-06-22 | EHRLICH JASON | nan | Sell | 6,950 | $60.54 | $420,747 | Yes |
| 2020-05-20 | EHRLICH JASON | See Remarks | Sell | 6,950 | $60.72 | $421,989 | Yes |
| 2020-04-20 | EHRLICH JASON | See Remarks | Sell | 6,950 | $54.12 | $376,115 | Yes |
| 2020-04-09 | EHRLICH JASON | See Remarks | Sell | 2,200 | $48.56 | $106,830 | Yes |
Insider Smart
Insider Smart